Lista de obras -

A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 23 de diciembre de 2010

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma

artículo científico publicado en 2014

AMP-activated protein kinase is essential for survival in chronic hypoxia

artículo científico

Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping

artículo científico publicado en 2016

Activation of PI3K signaling in Merkel cell carcinoma

artículo científico publicado en 2012

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer ⬇️

artículo científico publicado el 12 de octubre de 2010

BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults

artículo científico publicado en 2013

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications

artículo científico publicado en 2011

Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases

artículo científico publicado en 2017

Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.

artículo científico publicado en 2015

Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding

artículo científico publicado en 2013

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

artículo científico publicado en 2014

Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma

artículo científico publicado en 2014

Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.

artículo científico publicado en 2016

Decreased survival in EGFR gene amplified vulvar carcinoma

artículo científico publicado en 2008

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

artículo científico publicado en 2015

Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment

artículo científico publicado en 2012

Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts

artículo científico publicado en 2014

EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas

artículo científico publicado en 2011

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma

artículo científico publicado en 2016

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

artículo científico publicado en 2010

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

artículo científico publicado en 2015

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

artículo científico publicado en 2011

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

artículo científico publicado en 2020

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

artículo científico publicado en 2014

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant

artículo científico publicado en 2015

Inactivation of the tumor suppressor WTX in a subset of pediatric tumors

scientific article published on 05 November 2013

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model

artículo científico publicado en 2011

Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate

artículo científico publicado en 2014

L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

scientific article published on 01 February 2019

Microsatellite instability in gallbladder carcinoma

artículo científico publicado en 2015

Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer

artículo científico publicado en 2015

Mutational analysis and clinical correlation of metastatic colorectal cancer

artículo científico publicado en 2014

Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer

artículo científico publicado en 2014

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

artículo científico publicado en 2011

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

artículo científico publicado en 2015

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

artículo científico publicado en 2012

Prospective, high-throughput molecular profiling of human gliomas

artículo científico publicado en 2012

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

artículo científico publicado en 2015

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

artículo científico publicado en 2010

Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutation

artículo científico publicado en 2016

Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).

artículo científico

Standardized decision support in next generation sequencing reports of somatic cancer variants

artículo científico

Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma

artículo científico publicado en 2014

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

artículo científico publicado en 2014

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas

artículo científico publicado en 2016

Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53

artículo científico publicado en 2006

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

artículo científico publicado en 2014

Lista de obras de

A Platform for Rapid Detection of Multiple Oncogenic Mutations With Relevance to Targeted Therapy in Non–Small-Cell Lung Cancer ⬇️

A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma

AMP-activated protein kinase is essential for survival in chronic hypoxia

Acquired Resistance to Crizotinib in NSCLC with MET Exon 14 Skipping

Activation of PI3K signaling in Merkel cell carcinoma

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer ⬇️

BRAF V600E mutation identifies a subset of low-grade diffusely infiltrating gliomas in adults

BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications

Biliary Adenofibroma of Liver: Morphology, Tumor Genetics, and Outcomes in 6 Cases

Branched chain in situ hybridization for albumin as a marker of hepatocellular differentiation: evaluation of manual and automated in situ hybridization platforms.

Case records of the Massachusetts General Hospital. Case 14-2013. A 70-year-old woman with vaginal bleeding

Circulating oncometabolite 2-hydroxyglutarate is a potential surrogate biomarker in patients with isocitrate dehydrogenase-mutant intrahepatic cholangiocarcinoma

Clinical Grade "SNaPshot" Genetic Mutation Profiling in Multiple Myeloma

Colorectal cancer in Crohn's colitis is comparable to sporadic colorectal cancer.

Decreased survival in EGFR gene amplified vulvar carcinoma

Detection of Dual IDH1 and IDH2 Mutations by Targeted Next-Generation Sequencing in Acute Myeloid Leukemia and Myelodysplastic Syndromes.

Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment

Dual HER2 targeting impedes growth of HER2 gene-amplified uterine serous carcinoma xenografts

EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas

Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells

Erratum to: The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology

Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping

Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma

Genomic profiling of intrahepatic cholangiocarcinoma: refining prognosis and identifying therapeutic targets

HER2 over-expressing high grade endometrial cancer expresses high levels of p95HER2 variant

Inactivation of the tumor suppressor WTX in a subset of pediatric tumors

Inhibition of Hedgehog signaling antagonizes serous ovarian cancer growth in a primary xenograft model

Isocitrate dehydrogenase 1 (IDH1) mutation in breast adenocarcinoma is associated with elevated levels of serum and urine 2-hydroxyglutarate

L265P mutation and loss are early mutational events in primary central nervous system diffuse large B-cell lymphomas

Microsatellite instability in gallbladder carcinoma

Molecular Heterogeneity and Receptor Coamplification Drive Resistance to Targeted Therapy in MET-Amplified Esophagogastric Cancer

Mutational analysis and clinical correlation of metastatic colorectal cancer

Mutational and clinical predictors of pathologic complete response in the treatment of locally advanced rectal cancer

Phase 1/2 study of everolimus in advanced hepatocellular carcinoma

Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma

Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response

Prospective, high-throughput molecular profiling of human gliomas

RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine

Ridaforolimus improves the anti-tumor activity of dual HER2 blockade in uterine serous carcinoma in vivo models with HER2 gene amplification and PIK3CA mutation

Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).

Standardized decision support in next generation sequencing reports of somatic cancer variants

Synergistic effects of targeted PI3K signaling inhibition and chemotherapy in liposarcoma

Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.

Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas

Targeting of p300/CREB binding protein coactivators by simian virus 40 is mediated through p53

The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology